Items where authors include "Pickworth, J.A."

Article

Errington, N. orcid.org/0000-0001-6768-7394, Iremonger, J., Pickworth, J.A. orcid.org/0000-0002-7199-364X et al. (13 more authors) (2021) A diagnostic miRNA signature for pulmonary arterial hypertension using a consensus machine learning approach. EBioMedicine, 69. 103444. ISSN 2352-3964

Zawia, A., Arnold, N.D. orcid.org/0000-0002-4317-5738, West, L. orcid.org/0000-0003-2953-2521 et al. (9 more authors) (2021) Altered macrophage polarization induces experimental pulmonary hypertension and is observed in patients with pulmonary arterial hypertension. Arteriosclerosis, thrombosis, and vascular biology, 41 (1). pp. 430-445. ISSN 1079-5642

Arnold, N.D. orcid.org/0000-0002-4317-5738, Pickworth, J.A. orcid.org/0000-0002-7199-364X, West, L.E. et al. (24 more authors) (2019) A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension. Nature Communications, 10 (1). 5183. ISSN 2041-1723

Renshall, L.J., Arnold, N.D. orcid.org/0000-0002-4317-5738, West, L. et al. (10 more authors) (2018) Selective improvement of pulmonary arterial hypertension with a dual ETA/ETB receptors antagonist in the apolipoprotein E−/− model of PAH and atherosclerosis. Pulmonary Circulation , 8 (1). pp. 1-11. ISSN 2045-8932

Pickworth, J.A. orcid.org/0000-0002-7199-364X, Rothman, A., Iremonger, J. et al. (9 more authors) (2017) EXPRESS: Differential IL-1 signalling induced by BMPR2 deficiency drives pulmonary vascular remodelling. Pulmonary Circulation, 7 (4). pp. 768-776. ISSN 2045-8932

Hameed, A.G., Arnold, N.D., Chamberlain, J. et al. (12 more authors) (2012) Inhibition of tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension. The Journal of Experimental Medicine, 209 (11). 1919 - 1935. ISSN 0022-1007